Walmart Announces New, Low-Price Insulin For Diabetics.<br />Walmart Announces New, Low-Price Insulin For Diabetics.<br />Vials of the private-label version of <br />ReliOn NovoLog will be sold by Walmart to <br />uninsured patients with a prescription for $73.<br />Vials of the private-label version of <br />ReliOn NovoLog will be sold by Walmart to <br />uninsured patients with a prescription for $73.<br />Uninsured patients can also get packages <br />of pre-filled insulin pens for $86.<br />This price point, we hope, will improve and hopefully revolutionize the accessibility and affordability <br />of insulin, Dr. Cheryl Pegus, Walmart’s Executive Vice <br />President of Health and Wellness, via CNBC.<br />We know that many people with diabetes struggle to manage this chronic condition because of its financial burden, Dr. Cheryl Pegus, Walmart’s Executive Vice <br />President of Health and Wellness, via CNBC.<br />Walmart already offers a low-cost insulin for $25 a vial <br />through its ReliOn line of products.<br />But the new low-cost insulin is considered more <br />effective at regulating blood sugar. .<br />According to data from 2016, yearly insulin <br />costs for diabetics are about $5,700 on average
